LINC00673 is also clarified to suppress tumor progression by enhancing the binding of pre-mRNA processing factor 19 (PRPF19) to protein tyrosine phosphatase non-receptor type 11 (PTPN11), subsequently promoting PRPF19-mediated ubiquitination and degradation of PTPN11 (Zheng et al., 2016). The gene discussed is PRPF19; the disease is neoplasm.